GSTM1 and chronic kidney disease: Clinical guidelines (e.g., KDIGO 2021) recommend initiating anemia work-up in CKD patients with Hb < 12 g/dL and considering ESA therapy when Hb is <10 g/dL, after correcting iron deficiency.